// App-Quantinova.ai

e16071 : Corticosteroid use in mCRPC patients treated with abiraterone or enzalutamide using real world data from three databases.

Researchers

Presenter

  • Lorie Ellis

Principal Investigators

  • R. Scott McKenzie

  • Patrick Lefebvre

  • Dominic Pilon

  • Laurence Gozalo

  • Marie-Helene Lafeuille

Medical Centers

  • Janssen Scientific Affairs, Horsham, PA

  • Groupe d?analyse, Ltee, Montreal, QC, CanadaDe La Gauchetiere Ouest, Montreal, QC, CanadaGroupe danalyse, Montreal, QC, Canada

  • Groupe d'analyse, Ltee, Montreal, QC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Enzalutamide

  • CB-7598

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved